Opposition · USPTO

Opposition 91278464

OtherUSPTO

Opposition 91278464 at USPTO between Boehringer Ingelheim Pharma GmbH & Co. KG and Flagship Labs 83, Inc., over the mark MIRAPEUTICS, filed Sep 8, 2022. Status in the office record: other.

View MIRAPEUTICSGet this data via the API
Status
Other
Result
Other
Filed
Sep 8, 2022
Marks involved
2
Parties

Who is involved

The parties as named in the office record.

Opponent

Boehringer Ingelheim Pharma GmbH & Co. KG

Company trademarks
Respondent

Flagship Labs 83, Inc.

Timeline

How the case has moved

Dates from the USPTO record and the MIRAPEUTICS filing.

  1. MIRAPEUTICS filed

    Application 90879030 filed at the USPTO.

  2. Opposition filed

    Boehringer Ingelheim Pharma GmbH & Co. KG started opposition 91278464 at USPTO against MIRAPEUTICS.
Marks

Marks involved

1 contested mark, 1 mark the challenger relies on.

MarkRoleApplicationOffice
MIRAPEUTICSContested90879030USPTO
MIRAPEXRelied on75027783USPTO
API

Get this data via the API

Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.

  • GET/v1/proceedings/{id}

    Parties, dates, outcome and every mark in the case

  • GET/v1/proceedings?trademark_id={trademark_id}

    Every proceeding on a mark

Get API keyView docs
GET /v1/proceedings/{id}
ID=prc_d809099a-cdb2-419c-a860-95077f9a8e8a
curl https://api.signa.so/v1/proceedings/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "prc_d809099a-cdb2-419c-a860-95077f9a8e8a",
  "object": "proceeding",
  "proceeding_type": "opposition",
  "proceeding_number": "91278464",
  "status": "other",
  "office_code": "US",
  "filed_date": "2022-09-08",
  "parties": [
    {
      "name": "Boehringer Ingelheim Pharma GmbH & Co. KG",
      "role": "opponent"
    },
    {
      "name": "Flagship Labs 83, Inc.",
      "role": "respondent"
    }
  ]
}